References
- NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 2001;285: 785–95
- Riggs BL, Melton III LJ. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17\(Suppl. 5): 505S–511S
- Anon. Osteoporosis fast facts. Washington (DC): National Osteoporosis Foundation. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm [last accessed February 3, 2006]
- Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688–703
- Sullivan SD, Lyles A, Luce B, Grigar J. AMCP guidance for submission of clinical and economic evaluation data to support formulary listing in US health plans and pharmacy benefits management organizations. J Man Care Pharm 2001;7:272–82
- Langley PC, Sullivan SD. Pharmacoeconomic evaluations: guidelines for drug purchasers. J Man Care Pharm 1996;2:671–7
- Mauskopf JA, Earnshaw S, Mullins CD. Budget impact analysis: review of the state of the art. Future Drugs: Expert Rev Pharmacoeconomics Outcomes Res 2005;5:65–79
- Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics 2001;19:609–21
- Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001;7:293–312
- Anon. Osteoporosis diagnosis. Washington (DC): National Osteoporosis Foundation. Available at: http://www.nof.org/physguide/diagnosis.htm [last accessed February 17, 2006]
- Orsini LS, Rousculp MD, Long SR, Wang S. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporosis Int 2005;16:359–71
- Neumann PJ. Evidence-based and value-based formulary guidelines. Health Aff 2004;23:124–34
- Motheral BR, Fairman KA. The use of claims databases for outcomes research: rationale, challenges, and strategies. Clin Ther 1997;19:346–66